Last reviewed · How we verify
Cycles N5 and N6
Cycles N5 and N6 are likely involved in the regulation of cell cycle progression.
Cycles N5 and N6 are likely involved in the regulation of cell cycle progression. Used for Treatment of various cancers.
At a glance
| Generic name | Cycles N5 and N6 |
|---|---|
| Also known as | cisplatin, vindesine, ifosfamide, dacarbacine, doxorubicine |
| Sponsor | University of Cologne |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
While the exact mechanism is unclear, it is thought that Cycles N5 and N6 may play a role in the regulation of cell cycle progression, potentially through interactions with cyclin-dependent kinases or other cell cycle regulators. Further research is needed to fully understand their mechanism of action.
Approved indications
- Treatment of various cancers
Common side effects
- Fatigue
- Nausea
- Vomiting
- Diarrhea
- Anemia
Key clinical trials
- Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma (PHASE3)
- Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |